Megace ES 625 MG per 5 ML Oral Suspension
- RxCUI
- 885111
- RxNorm name
- Megace ES 625 MG per 5 ML Oral Suspension
- Display name
- Megace ES 625 MG per 5 ML Oral Suspension
- Full name
- Megace ES 625 MG per 5 ML Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 654854bc-f847-4e3b-a0a1-8716553460ac | Megace ES 625 MG per 5 ML Oral Suspension | SY | 3 | These highlights do not include all the information needed to use Megace ES safely and effectively. See full prescribing information for Megace ES. Megace ES (megestrol acetate, USP) Oral Suspension Initial U.S. Approval: 1993 ® ® ® | 20140318 |
| 654854bc-f847-4e3b-a0a1-8716553460ac | Megace ES 125 MG/ML Oral Suspension | SY | 3 | These highlights do not include all the information needed to use Megace ES safely and effectively. See full prescribing information for Megace ES. Megace ES (megestrol acetate, USP) Oral Suspension Initial U.S. Approval: 1993 ® ® ® | 20140318 |
| 654854bc-f847-4e3b-a0a1-8716553460ac | megestrol acetate 125 MG/ML Oral Suspension [Megace] | SBD | 3 | These highlights do not include all the information needed to use Megace ES safely and effectively. See full prescribing information for Megace ES. Megace ES (megestrol acetate, USP) Oral Suspension Initial U.S. Approval: 1993 ® ® ® | 20140318 |
| 654854bc-f847-4e3b-a0a1-8716553460ac | MEGACE ES 625 MG in 5 mL Oral Suspension | PSN | 3 | These highlights do not include all the information needed to use Megace ES safely and effectively. See full prescribing information for Megace ES. Megace ES (megestrol acetate, USP) Oral Suspension Initial U.S. Approval: 1993 ® ® ® | 20140318 |
| 33bc102c-31a3-4fd9-9702-c1193d7699a3 | MEGACE ES 625 MG in 5 mL Oral Suspension | PSN | 2 | MEGACE ES (megestrol acetate oral suspension) suspension | 20091027 |
| 33bc102c-31a3-4fd9-9702-c1193d7699a3 | Megace ES 625 MG per 5 ML Oral Suspension | SY | 2 | MEGACE ES (megestrol acetate oral suspension) suspension | 20091027 |
| 33bc102c-31a3-4fd9-9702-c1193d7699a3 | Megace ES 125 MG/ML Oral Suspension | SY | 2 | MEGACE ES (megestrol acetate oral suspension) suspension | 20091027 |
| 33bc102c-31a3-4fd9-9702-c1193d7699a3 | megestrol acetate 125 MG/ML Oral Suspension [Megace] | SBD | 2 | MEGACE ES (megestrol acetate oral suspension) suspension | 20091027 |
| e3e96f8d-31a6-4457-8e05-02579b539b8a | megestrol acetate 125 MG/ML Oral Suspension [Megace] | SBD | 1 | These highlights do not include all the information needed to use Megace® ES safely and effectively. See full prescribing information for Megace® ES. Megace ES (megestrol acetate) Oral Suspension Initial U.S. Approval: 1993 | 20110330 |
| e3e96f8d-31a6-4457-8e05-02579b539b8a | MEGACE ES 625 MG in 5 mL Oral Suspension | PSN | 1 | These highlights do not include all the information needed to use Megace® ES safely and effectively. See full prescribing information for Megace® ES. Megace ES (megestrol acetate) Oral Suspension Initial U.S. Approval: 1993 | 20110330 |
| e3e96f8d-31a6-4457-8e05-02579b539b8a | Megace ES 625 MG per 5 ML Oral Suspension | SY | 1 | These highlights do not include all the information needed to use Megace® ES safely and effectively. See full prescribing information for Megace® ES. Megace ES (megestrol acetate) Oral Suspension Initial U.S. Approval: 1993 | 20110330 |
| e3e96f8d-31a6-4457-8e05-02579b539b8a | Megace ES 125 MG/ML Oral Suspension | SY | 1 | These highlights do not include all the information needed to use Megace® ES safely and effectively. See full prescribing information for Megace® ES. Megace ES (megestrol acetate) Oral Suspension Initial U.S. Approval: 1993 | 20110330 |